Gerhard F. Ecker

Research interests

Publications

• In silico toxicology: From structure–activity relationships towards deep learning and adverse outcome pathways

  Wiley Interdisciplinary Reviews Computational Molecular Science · 2020 · 10.1002/wcms.1475

• Translation Termination Factor GSPT1 Is a Phenotypically Relevant Off-Target of Heterobifunctional Phthalimide Degraders

  ACS Chemical Biology · 2018 · 10.1021/acschembio.7b00969

• Adverse outcome pathways: opportunities, limitations and open questions

  Archives of Toxicology · 2017 · https://doi.org/10.1007/s00204-017-2045-3

• Kinetics for Drug Discovery: an industry-driven effort to target drug residence time

  Drug Discovery Today · 2017 · 10.1016/j.drudis.2017.02.002

• Prediction of drug–ABC-transporter interaction — Recent advances and future challenges

  Advanced Drug Delivery Reviews · 2015 · 10.1016/j.addr.2015.03.001

• Mesonic Low-Energy Constants

  Annual Review of Nuclear and Particle Science · 2014 · 10.1146/annurev-nucl-102313-025528

• Kaon decays in the standard model

  Reviews of Modern Physics · 2012 · https://doi.org/10.1103/revmodphys.84.399

• Open PHACTS: semantic interoperability for drug discovery

  Drug Discovery Today · 2012 · 10.1016/j.drudis.2012.05.016

• Evidence-based approach to assess passive diffusion and carrier-mediated drug transport

  Drug Discovery Today · 2012 · 10.1016/j.drudis.2012.03.015

• Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligands

  Nature Chemical Biology · 2012 · 10.1038/nchembio.917

• Coexistence of passive and carrier-mediated processes in drug transport

  Nature Reviews Drug Discovery · 2010 · https://doi.org/10.1038/nrd3187

• On the relationship between feature selection and classification accuracy

  Phaidra (Universität Wien) · 2008

• Towards a consistent estimate of the chiral low-energy constants

  Nuclear Physics B · 2006 · 10.1016/j.nuclphysb.2006.07.010

• Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure–activity relationship

  Bioorganic & Medicinal Chemistry · 2004 · 10.1016/j.bmc.2004.08.008

• Renormalization of Chiral Perturbation Theory to Order p6

  Annals of Physics · 2000 · 10.1006/aphy.1999.5982

• The mesonic chiral lagrangean of order p6

  Journal of High Energy Physics · 1999 · 10.1088/1126-6708/1999/02/020

• Pion-pion scattering at low energy

  Nuclear Physics B · 1997 · 10.1016/s0550-3213(97)80013-2

• Elastic ππ scattering to two loops

  Physics Letters B · 1996 · 10.1016/0370-2693(96)00165-7

• Chiral perturbation theory

  Progress in Particle and Nuclear Physics · 1995 · https://doi.org/10.1016/0146-6410(95)00041-g

• Radiative semileptonic kaon decays

  Nuclear Physics B · 1993 · 10.1016/0550-3213(93)90259-r

• Chiral lagrangians for massive spin-1 fields

  Physics Letters B · 1989 · https://doi.org/10.1016/0370-2693(89)91627-4

• The role of resonances in chiral perturbation theory

  Nuclear Physics B · 1989 · https://doi.org/10.1016/0550-3213(89)90346-5

• Radiative Kaon decays and CP violation in chiral perturbation theory

  Nuclear Physics B · 1988 · 10.1016/0550-3213(88)90425-7

• K → πℓ+ℓ− decays in the effective chiral lagrangian of the standard model

  Nuclear Physics B · 1987 · 10.1016/0550-3213(87)90491-3

• CP violation and left-right symmetry

  Nuclear Physics B · 1985 · 10.1016/0550-3213(85)90616-9

Current projects

No projects listed.